Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1995 Mar;41:457-8, 461-2, 465-8.

Evaluating tall children.

A K Leung 1, W L Robson 1
PMCID: PMC2148014  PMID: 7773029

Abstract

The causes of tall stature are numerous; genetic tall stature and constitutional tall stature are the most common. Diagnosis can usually be established from the history and physical examination. An estimation of bone age can help to confirm diagnosis and to determine the child's growth potential. No treatment is usually necessary. Hormonal therapy can be considered for individuals for whom the predicted height is excessive if the psychosocial and medical advantages outweigh the risks of treatment.

Full text

PDF
457

Images in this article

462p462-a
on p.462

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blombäck M., Hall K., Ritzén E. M. Estrogen treatment of tall girls: risk of thrombosis? Pediatrics. 1983 Sep;72(3):416–419. [PubMed] [Google Scholar]
  2. Brämswig J. H., Nieschlag E., Schellong G. Pituitary-gonadal function in boys after high dose testosterone treatment for excessively tall stature. Acta Endocrinol (Copenh) 1984 Sep;107(1):97–103. doi: 10.1530/acta.0.1070097. [DOI] [PubMed] [Google Scholar]
  3. Brämswig J. H., von Lengerke H. J., Schmidt H., Schellong G. The results of short-term (6 months) high-dose testosterone treatment on bone age and adult height in boys of excessively tall stature. Eur J Pediatr. 1988 Nov;148(2):104–106. doi: 10.1007/BF00445913. [DOI] [PubMed] [Google Scholar]
  4. Clark R. D., Donnai D., Rogers J., Cooper J., Baraitser M. Proteus syndrome: an expanded phenotype. Am J Med Genet. 1987 May;27(1):99–117. doi: 10.1002/ajmg.1320270111. [DOI] [PubMed] [Google Scholar]
  5. Dickerman Z., Loewinger J., Laron Z. The pattern of growth in children with constitutional tall stature from birth to age 9 years. A longitudinal study. Acta Paediatr Scand. 1984 Jul;73(4):530–536. doi: 10.1111/j.1651-2227.1984.tb09966.x. [DOI] [PubMed] [Google Scholar]
  6. Engström W., Lindham S., Schofield P. Wiedemann-Beckwith syndrome. Eur J Pediatr. 1988 Jun;147(5):450–457. doi: 10.1007/BF00441965. [DOI] [PubMed] [Google Scholar]
  7. Hindmarsh P. C., Pringle P. J., Di Silvio L., Brook C. G. A preliminary report on the role of somatostatin analogue (SMS 201-995) in the management of children with tall stature. Clin Endocrinol (Oxf) 1990 Jan;32(1):83–91. doi: 10.1111/j.1365-2265.1990.tb03753.x. [DOI] [PubMed] [Google Scholar]
  8. Joss E. E., Temperli R., Mullis P. E. Adult height in constitutionally tall stature: accuracy of five different height prediction methods. Arch Dis Child. 1992 Nov;67(11):1357–1362. doi: 10.1136/adc.67.11.1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kuhn N., Blunck W., Stahnke N., Wiebel J., Willig R. P. Estrogen treatment in tall girls. Acta Paediatr Scand. 1977 Mar;66(2):161–167. doi: 10.1111/j.1651-2227.1977.tb07828.x. [DOI] [PubMed] [Google Scholar]
  10. Leung A. K., McArthur R. G. Recent Advances in the Treatment of Isosexual Precocious Puberty: Identifying all the problems. Can Fam Physician. 1991 Dec;37:2597–2604. [PMC free article] [PubMed] [Google Scholar]
  11. Leung A. K., McArthur R. G., Ross S. A., McMillan D. D., Sauve R. S. Thyroxine-binding globulin deficiency in Beckwith syndrome. J Pediatr. 1979 Nov;95(5 Pt 1):752–754. doi: 10.1016/s0022-3476(79)80730-1. [DOI] [PubMed] [Google Scholar]
  12. Leung A. K., Robson W. L. Childhood obesity. Postgrad Med. 1990 Mar;87(4):123-30, 133. doi: 10.1080/00325481.1990.11704600. [DOI] [PubMed] [Google Scholar]
  13. Marshall W. A., Tanner J. M. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969 Jun;44(235):291–303. doi: 10.1136/adc.44.235.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McClain L. G. The tall athlete and Marfan syndrome. Need for clinical differentiation. J Adolesc Health Care. 1989 Nov;10(6):564–566. doi: 10.1016/0197-0070(89)90026-0. [DOI] [PubMed] [Google Scholar]
  15. Mudd S. H., Skovby F., Levy H. L., Pettigrew K. D., Wilcken B., Pyeritz R. E., Andria G., Boers G. H., Bromberg I. L., Cerone R. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985 Jan;37(1):1–31. [PMC free article] [PubMed] [Google Scholar]
  16. Normann E. K., Trygstad O., Larsen S., Dahl-Jørgensen K. Height reduction in 539 tall girls treated with three different dosages of ethinyloestradiol. Arch Dis Child. 1991 Nov;66(11):1275–1278. doi: 10.1136/adc.66.11.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Panteon E., Loumaye E., Maes M., Malvaux P. Occurrence of prolactinoma after estrogen treatment in a girl with constitutional tall stature. J Pediatr. 1988 Aug;113(2):337–339. doi: 10.1016/s0022-3476(88)80279-8. [DOI] [PubMed] [Google Scholar]
  18. Prader A., Zachmann M. Treatment of excessively tall girls and boys with sex hormones. Pediatrics. 1978 Dec;62(6 Pt 2):1202–1210. [PubMed] [Google Scholar]
  19. Schoen E. J., Solomon I. L., Warner O., Wingerd J. Estrogen treatment of tall girls. Am J Dis Child. 1973 Jan;125(1):71–74. doi: 10.1001/archpedi.1973.04160010045010. [DOI] [PubMed] [Google Scholar]
  20. Skogland L. B., Steen H., Trygstad O. Spinal deformities in tall girls. Acta Orthop Scand. 1985 Apr;56(2):155–157. doi: 10.3109/17453678508994344. [DOI] [PubMed] [Google Scholar]
  21. Tauber M. T., Tauber J. P., Vigoni F., Harris A. G., Rochicchioli P. Effect of the long-acting somatostatin analogue SMS 201-995 on growth rate and reduction of predicted adult height in ten tall adolescents. Acta Paediatr Scand. 1990 Feb;79(2):176–181. doi: 10.1111/j.1651-2227.1990.tb11435.x. [DOI] [PubMed] [Google Scholar]
  22. Viljoen D. L., Nelson M. M., de Jong G., Beighton P. Proteus syndrome in southern Africa: natural history and clinical manifestations in six individuals. Am J Med Genet. 1987 May;27(1):87–97. doi: 10.1002/ajmg.1320270110. [DOI] [PubMed] [Google Scholar]
  23. Weaver D. D., Graham C. B., Thomas I. T., Smith D. W. A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. J Pediatr. 1974 Apr;84(4):547–552. doi: 10.1016/s0022-3476(74)80675-x. [DOI] [PubMed] [Google Scholar]
  24. Werder E. A., Waibel P., Sege D., Flury R. Severe thrombosis during oestrogen treatment for tall stature. Eur J Pediatr. 1990 Mar;149(6):389–390. doi: 10.1007/BF02009654. [DOI] [PubMed] [Google Scholar]
  25. Wettenhall H. N., Cahill C., Roche A. F. Tall girls: a survey of 15 years of management and treatment. J Pediatr. 1975 Apr;86(4):602–610. doi: 10.1016/s0022-3476(75)80162-4. [DOI] [PubMed] [Google Scholar]
  26. Zachmann M., Ferrandez A., Mürset G., Gnehm H. E., Prader A. Testosterone treatment of excessively tall boys. J Pediatr. 1976 Jan;88(1):116–123. doi: 10.1016/s0022-3476(76)80742-1. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES